Addressing Tumor Board Bad Habits and Risks: A Call for Rational Resource Management Fig 1. Summary of germline and somatic genomic testing for metastatic prostate cancer recommendations. ARPI, ...

It has been estimated that 5% to 10% of cancers are due to hereditary causes. Recent data sets indicate that the incidence of hereditary cancer may be as high as 17.5% in patients with cancer, and a ...

Cancer is driven mainly by genomic instability, manifesting through a spectrum of somatic mutations that range from single nucleotide substitutions to large-scale chromosomal rearrangements, which ...

Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and somatic, is ...

The immune system relies on B cells to produce antibodies that fight infections, but the way these cells evolve to recognize threats more effectively remains a puzzle. In a recent study published in ...